Kanis, John A. http://orcid.org/0000-0002-3129-4326
Johansson, Helena
Harvey, Nicholas C.
Lorentzon, Mattias
Liu, Enwu
Vandenput, Liesbeth
Morin, Suzanne
Leslie, William D.
McCloskey, Eugene V.
Article History
Received: 23 September 2022
Accepted: 1 December 2022
First Online: 23 December 2022
Declarations
: The study was approved by the Health Research Ethics Board for the University of Manitoba.
: W Leslie, E Liu, S Morin, L Vandenput, and H Johansson have no competing interests to declare.N. Harvey has received consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Radius Health, and Internis Pharma.EV McCloskey has received consultancy/lecture fees/grant funding/honoraria from Amgen, Consilient Healthcare, Fresenius Kabi, Gilead, Internis, Lilly, ObsEva, Radius Health, Redx Oncology, UCB, and I3 Innovus.JA Kanis is the architect of FRAX.M Lorentzon has received lecture fees from Amgen, Lilly, Meda, Renapharma, UCB Pharma, and consulting fees from Amgen, Radius Health, UCB Pharma, Renapharma, and Consilient Health, all outside the presented work.